Inhibikase Therapeutics, Inc. Warrant Agreements
30 Contracts & Agreements
- Form of Series B-1 Warrant (Filed With SEC on October 10, 2024)
- Form of Series A-1 Warrant (Filed With SEC on October 10, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on October 10, 2024)
- Form of Warrant Amendment (Filed With SEC on May 20, 2024)
- Form of Series D Warrant (Filed With SEC on May 20, 2024)
- Form of Series C Warrant (Filed With SEC on May 20, 2024)
- Form of Series B Warrant (Filed With SEC on May 20, 2024)
- Form of Series A Warrant (Filed With SEC on May 20, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on May 20, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on May 9, 2024)
- Form of Common Warrant (Filed With SEC on May 9, 2024)
- Form of Placement Agent Warrant (Filed With SEC on April 25, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 25, 2024)
- Form of Common Warrant (Filed With SEC on April 25, 2024)
- Form of Placement Agent Warrant (Filed With SEC on January 26, 2023)
- Form of PIPE Common Warrant (Filed With SEC on January 26, 2023)
- Form of PIPE Pre-Funded Warrant (Filed With SEC on January 26, 2023)
- Form of Private Common Warrant (Filed With SEC on January 26, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on January 26, 2023)
- Form of Representatives Warrant Agreement (Filed With SEC on June 16, 2021)
- Form of Representatives Warrant (Filed With SEC on June 11, 2021)
- Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020 (Filed With SEC on September 15, 2020)
- Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020 (Filed With SEC on September 15, 2020)
- Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2019 (Filed With SEC on September 15, 2020)
- Form of Late IPO Warrant (Filed With SEC on July 23, 2020)
- Form of Representatives Warrant (Filed With SEC on July 23, 2020)
- Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated March 31, 2020 (Filed With SEC on July 23, 2020)
- Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2020 (Filed With SEC on July 23, 2020)
- Warrant dated October 5, 2018, issued by Inhibikase Therapeutics, Inc. to Kubera North America, Inc (Filed With SEC on July 23, 2020)
- Form of Warrant to purchase common stock of the Registrant, issued to each of the investors named in Schedule A thereto (Filed With SEC on July 23, 2020)
